New advances in breast cancer metastasis

Women's Health

Volumn 4, Issue 6, 2008, Pages 547-549

  Russo, Jose ^a   Han, Hye Jung ^b   Kohwi, Yoshinori ^b   Kohwi Shigematsu, Terumi ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SATB1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER GENETICS; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL ACTIVITY; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELL SURVIVAL; DISEASE ACTIVITY; DNA MICROARRAY; DNA SEQUENCE; DOWN REGULATION; EDITORIAL; EPITHELIUM CELL; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SILENCING; GENE TARGETING; HUMAN; LYMPH NODE METASTASIS; MESENCHYME CELL; METASTASIS; ONCOGENE; OVERALL SURVIVAL; PHENOTYPE; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; TUMOR VASCULARIZATION; UPREGULATION;

BREAST NEOPLASMS; CADHERINS; FEMALE; HUMANS; MATRIX ATTACHMENT REGION BINDING PROTEINS; NEOPLASM METASTASIS; PROGNOSIS;

EID: 59349120265     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.4.6.547     Document Type: Editorial

References (25)

1. Boyle P, d'Onofrio A, Maisonneuve P et al.: Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? Ann. Oncol. 14, 1312-1325 (2003).
2. Ahmad A, Hart IR: Mechanisms of metastasis. Crit. Rev. Oncol. Hematol. 26, 163-173 (1997).
3. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. 3, 453-458 (2003).
4. Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12, 895-904 (2006).
5. Weigelt B, Peterse JL, van't Veer LJ: Breast cancer metastasis: markers and models. Nat. Rev. 5, 591-602 (2005).
6. Nguyen DX, Massague J: Genetic determinants of cancer metastasis. Nat. Rev. Genet. 8, 341-352 (2007).
7. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T: SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452, 187-193 (2008).
8. Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T: A tissue-specific MAR/ SAR DNA-binding protein with unusual binding site recognition. Cell 70, 631-645 (1992).
9. Kohwi-Shigematsu T, Kohwi Y: Torsional stress stabilizes extended base unpairing in suppressor sites flanking immunoglobulin heavy chain enhancer. Biochemistry 29, 9551-9560 (1990).
10. Bode J, Kohwi Y, Dickinson L et al.: Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science 255, 195-197 (1992).
11. Cai S, Han HJ, Kohwi-Shigematsu T: Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat. Genet. 34, 42-51 (2003).
12. Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY, Kohwi-Shigematsu T: The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev. 14, 521-535 (2000).
13. Cai S, Lee CC, Kohwi-Shigematsu T: SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat. Genet. 38, 1278-1288 (2006).
14. Helfman DM, Kim EJ, Lukanidin E, Grigorian M: The metastasis associated protein S100A4: role in tumour progression and metastasis. Br. J. Cancer 92, 1955-1958 (2005).
15. + lymphatic/vascular endothelial precursor cells. Blood 101, 168-172 (2003).
16. Dumont N, Arteaga CL: Targeting the TGF β signaling network in human neoplasia. Cancer cell 3, 531-5366 (2003).
17. Kang Y, Siegel PM, Shu W et al.: A multigenic program mediating breast cancer metastasis to bone. Cancer cell 3, 537-549 (2003).
18. Moussad EE, Brigstock DR: Connective tissue growth factor: what's in a name? Mol. Genet. Metab. 71, 276-292 (2000)
19. Mosesson Y, Yarden Y: Oncogenic growth factor receptors: implications for signal transduction therapy. Semin. Cancer Biol. 14, 262-270 (2004).
20. de Bono JS, Rowinsky EK: The ErbB receptor family: a therapeutic target for cancer. Trends Mol. Med. 8, S19-S26 (2002).
21. Huang Y, Fernandez SV, Goodwin S et al.: Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17β-estradiol. Cancer Res. 67, 11147-11157 (2007).
22. Christiansen JJ, Rajasekaran AK: Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 66, 8319-8326 (2006).
23. Brembeck FH, Rosario M, Birchmeier W: Balancing cell adhesion and Wnt signaling, the key role of β-catenin. Curr. Opin. Genet. Dev. 16, 51-59 (2006).
24. Berx G, Van Roy F: The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 3, 289-293 (2001).
25. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. 2, 442-454 (2002).